Accueil › Lymphome › District de Columbia › Washington
Essais cliniques pour Lymphome à Washington, DC
23 études pour Lymphome recherchent des participants dans et autour de Washington (dans un rayon d'environ 30 miles). Ouvrez une étude pour voir qui peut participer et comment contacter l'équipe.
Texte officiel de l'étude (anglais)
Vous recrutez pour une étude ? Mettez-la en avant en haut de cette page — $99 pour 30 jours →
Nivolumab in Epstein-Barr Virus (EBV)-Positive Lymphoproliferative Disorders and EBV-Positive Non-HodgkinLymphomas
Recrutement en coursPhase 2
- National Institutes of Health Clinical Center, Bethesda · à 7 mi
Collection of Blood From Patients With Cancer, Other Tumors, or Tumor Predisposition Syndromes for Genetic Analysis
Recrutement en coursÉtude observationnelle
- National Institutes of Health Clinical Center, Bethesda · à 7 mi
CD19/CD22 Bicistronic Chimeric Antigen Receptor (CAR) T Cells in Children and Young Adults With Recurrent or Refractory B Cell Malignancies
Recrutement en coursPhase 1/2
- National Institutes of Health Clinical Center, Bethesda · à 7 mi
Specimen Collections From Participants With HIV Infection, KSHV Infection, Viral-Related Pre-malignant Lesions and Cancer
Recrutement en coursÉtude observationnelle
- National Institutes of Health Clinical Center, Bethesda · à 7 mi
Venetoclax, Ibrutinib, Prednisone, Obinutuzumab, and Revlimid (ViPOR) in Relapsed/Refractory B-cell Lymphoma
Recrutement en coursPhase 1/2
- National Institutes of Health Clinical Center, Bethesda · à 7 mi
Natural History Study of Monoclonal B Cell Lymphocytosis (MBL), Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (CLL/SLL), Lymphoplasmacytic Lymphoma (LPL)/Waldenstrom Macroglobulinemia (WM), and Splenic Marginal Zone Lymphoma (SMZL)
Recrutement en coursÉtude observationnelle
- National Institutes of Health Clinical Center, Bethesda · à 7 mi
A Study of NX-5948 in Adults With CLL/SLL Previously Treated With a Bruton's Tyrosine Kinase Inhibitor and a B-cell Lymphoma-2 Inhibitor (DAYBreak CLL-201)
Recrutement en coursPhase 2
- Maryland Oncology Hematology, Silver Spring · à 7 mi
Collection of Tissue Samples for Cancer Research
Recrutement en coursÉtude observationnelle
- National Institutes of Health Clinical Center, Bethesda · à 7 mi
CBL0137 for the Treatment of Relapsed or Refractory Solid Tumors, Including CNS Tumors and Lymphoma
Recrutement en coursPhase 1/2
- Children's National Medical Center, Washington D.C.
Surovatamig as Consolidation Therapy in Participants With Chronic Lymphocytic Leukaemia or Small Lymphocytic Lymphoma With Unmutated Immunoglobulin Heavy Chain Variable (IGHV)
Recrutement en coursPhase 3
- Research Site, Bethesda · à 7 mi
Sample Collection and Tracking for the Developmental Therapeutics Clinic
Recrutement en coursÉtude observationnelle
- National Institutes of Health Clinical Center, Bethesda · à 7 mi
Toxin Exposure and Immune Dysregulation in Non-Hodgkin Lymphoma
Recrutement en coursÉtude observationnelle
- Walter Reed National Military Medical Center, Bethesda · à 7 mi
A Study to Evaluate Glofitamab as a Single Agent vs. Investigator's Choice in Participants With Relapsed/Refractory Mantle Cell Lymphoma
Recrutement en coursPhase 3
- Georgetown University, Washington D.C.
Cognitive Aftereffects of Neurotoxicity in Children and Young Adults With Relapsed/Refractory Hematologic Malignancies Who Receive CAR T-cell Therapy
Recrutement en coursÉtude observationnelleVolontaires sains bienvenus
- National Institutes of Health Clinical Center, Bethesda · à 7 mi
Study of Rondecabtagene Autoleucel in Aggressive Large B-Cell Lymphoma
Recrutement en coursPhase 1/2
- Medstar Georgetown University Hospital, Washington D.C.
A Study of Mosunetuzumab Alone or With Zanubrutinib in People With Follicular Lymphoma
Recrutement en coursPhase 2
- Georgetown University (Data Collection Only), Washington D.C.
A Study to Investigate Ronde-cel Versus Investigator's Choice CD19 CAR T-Cell Therapy
Recrutement en coursPhase 3
- MedStar Georgetown University Hospital, Washington D.C.
Vaccine Responses in Patients With B Cell Malignancies
Recrutement en coursPhase 4
- National Institutes of Health Clinical Center, Bethesda · à 7 mi
Mosaic Trial for Stem Cell Transplant Recipients
Recrutement en cours
- Georgetown University School of Medicine, Washington D.C.
A Study of NX-5948 in Adults With Relapsed/Refractory B-cell Malignancies
Recrutement en coursPhase 1
- National Institute of Health, Bethesda · à 7 mi
Collecting Blood and Tissue Sample Donations for Research for HIV/AIDS-Related Cancers
Recrutement en coursÉtude observationnelle
- George Washington University, Washington D.C.
Natural History Study to Determine Drug Metabolism Phenotype and Appropriate Germline Source DNA in Patients Undergoing Allogeneic Hematopoietic Stem Cell Transplant
Recrutement en coursÉtude observationnelleVolontaires sains bienvenus
- National Institutes of Health Clinical Center, Bethesda · à 7 mi
A Study of NX-2127 in Adults With Relapsed/Refractory B-cell Malignancies
Recrutement en coursPhase 1
- National Institutes of Health Clinical Center, Bethesda · à 7 mi
Essais pour Lymphome dans d'autres villes
- Houston, TX34 études
- Boston, MA33 études
- New York City, NY33 études
- Baldwin Park, CA21 études
- Chicago, IL20 études
- Durham, NC17 études
- St. Louis, MO15 études
- Philadelphia, PA15 études
- Cleveland, OH14 études
- Edison, NJ12 études
- Atlanta, GA12 études
- Seattle, WA12 études
Autres études à Washington
- Cancer (tous types)58 études
- Cancer du poumon non à petites cellules55 études
- Cancer du sein46 études
- Cancer métastatique43 études
- Cancer du poumon41 études
- Cancer de la prostate38 études
- Obésité33 études
- Cancer colorectal29 études
- Maladie cardiovasculaire28 études
- Cancer de la vessie26 études
- Leucémie aiguë myéloïde24 études
- Cancer de l'ovaire23 études
Source : ClinicalTrials.gov, données récupérées le 6 oct. 2026. Chaque étude définit ses propres critères d'éligibilité ; l'équipe de l'étude décide qui peut y participer.